Drug · CHEMBL720

BENZYL ALCOHOL

7 sourcespipelines-2026-09-18-0.3.1

Cite this record

ConductScience Library. BENZYL ALCOHOL. Drugs and targets, record CHEMBL720. Release pipelines-2026-09-18-0.3.1, 18 Sept 2026. https://conductscience.org/library/drugs/CHEMBL720

On this page

Drug

Names and IDs as ChEMBL gives them, through Open Targets.

Name: BENZYL ALCOHOL; ChEMBL
ChEMBL ID: CHEMBL720; ChEMBL
Type: Small molecule; ChEMBL
Brand names: Ulesfia; ChEMBL
Other names: Alcohol bencilico, Alcohol benzylicus, Alcohol, benzyl, Alcohol,benzyl, Alcool benzylique, E-1519, E1519, FEMA NO. 2137, INS NO.1519, INS-1519, NSC-8044; ChEMBL
DrugBank: DB06770; DrugBank
InChIKey: WVDDGKGOMKODPV-UHFFFAOYSA-N; ChEMBL
Open Targets' highest stage: Approval, for 3 of its 3 diseases, from ATC and DailyMed; Open Targets

Targets0

The targets ChEMBL's mechanism records give for the drug, through Open Targets. A mechanism record says what the drug acts on, not how strongly.

None in this release.

Diseases3

The diseases Open Targets' clinical reports study the drug for, the most trial reports first. The stage is Open Targets', the highest any of its sources reports for the pair, and each row names the sources that report it.

Disease	Open Targets' stage	Stage reported by	Reports	Of them trials	Its drugs
lice infestation	Approval	DailyMed	4	1	https://conductscience.org/library/drugs?q=MONDO_0003472
otitis externa	Approval	DailyMed	2	0	https://conductscience.org/library/drugs?q=MONDO_0004795
parasitic infectious disease	Approval	ATC	1	0	https://conductscience.org/library/drugs?q=MONDO_0005135

Source Open Targets

Trials5

Trials whose record names the drug by a name ChEMBL states, posted results first, then the largest. Open Targets read each trial's text to find its drugs.

Trial	Title	Phase	Participants	Results first posted	Named as	Linked by	Source
NCT02624843	Bioequivalence Study for Benzyl Alcohol Lotion 5%.	Phase 3	239	2020-09-03	benzyl alcohol	Its name	ClinicalTrials.gov
NCT02162680	An Evaluation of the Effectiveness of Local Anesthetics Used During Intravenous Catheter Insertion	Phase 4	99	2014-08-15	benzyl alcohol	Its name	ClinicalTrials.gov
NCT00301340	Efficacy and Safety of Summers Non-Pesticide Lice Asphyxiator (L.A.)for the Treatment of Head Lice	Phase 3	200		benzyl alcohol	Its name	ClinicalTrials.gov
NCT00301327	Efficacy and Safety of Summers Non-Pesticide Lice Asphyxiator (L.A.)for the Treatment of Head Lice.	Phase 3	120		benzyl alcohol	Its name	ClinicalTrials.gov
NCT00479310	Efficacy and Safety of Summers Non-Pesticide Lice Asphyxiator (L.A.)for the Treatment of Head Lice	Phase 3	120		benzyl alcohol	Its name	ClinicalTrials.gov

Comparisons in its trials0

Comparisons Trial comparisons calculated in the trials whose record names the drug, most participants first. A comparison in one of its trials does not always compare the drug, so read the two groups.

None in this release.

Papers from its trials1

The papers the trials whose record names the drug list on ClinicalTrials.gov as their results (RESULT) or as drawn from them (DERIVED), results first, newest first.

PMID	Listed as	Trials listing it
20199404	DERIVED	3

Source PubMed

Tests in its trials0

The tests ConductCognition runs that the trials whose record names the drug name in their registered outcomes, as ScienceGraph matched them. ConductCognition's list names the tests it runs, not every test a trial used.

None in this release.

Data dates

The date of each source this release read.

Open Targets: 2026-09-18; Open Targets
ClinicalTrials.gov: 2026-11-05; ClinicalTrials.gov
Results, from AACT: 2026-03-23; AACT
Papers the trials list, from Trials: 2026-11-12; Trials
Comparisons, from Trial comparisons: 2026-03-23; Trial comparisons
Tests named in the trials, as ScienceGraph matched them: 2026-11-12; ConductCognition

Sources 7

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ChEMBL, through Open TargetsCC BY-SA 3.0
ConductCognition's list of its testsOur own data
ClinicalTrials.govNo license stated
NLM's MeSHNLM's terms
Open TargetsCC0 1.0
PubMedNLM's terms

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ConductCognition's list of its testsOur own data: ConductCognition's list of its tests, https://conductcognition.com
ClinicalTrials.govnone stated
NLM's MeSHNLM's
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PubMedNLM's terms

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this drug from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/drugs/v1/CHEMBL720

GET https://conductscience.org/api/drugs/v1/CHEMBL720/targets

API reference For AI assistants